Buy Glycomet 850mg Online
Glycomet 850 MG Tablet SR is a drug that helps maintain balanced blood sugar levels in the body. It is used to treat Type 2 diabetes, heart disorders and polycystic ovary syndrome.
Glycomet 850 MG Tablet SR works by decreasing the amount of glucose produced by the liver. It suppresses the quantity of glucose that the liver releases in the body. Thus, it lowers the blood sugar levels in the body of a patient suffering from Type 2 diabetes. Glycomet 850 MG Tablet SR also increases your sensitivity to insulin, enabling your body to absorb larger quantities of glucose. This drug is available in oral solution or even tablet form.
Glycomet 850 MG Tablet SR is an oral drug that is used to control and balance blood sugar levels. This medication is used in the treatment of conditions such as type 2 diabetes, obesity, cardiovascular diseases, hypertension and polycystic ovarian syndrome. If you do not manage the condition of diabetes, it can result in kidney failure, obesity and heart disorders. Therefore, Glycomet 850 MG Tablet SR helps keep your blood sugar levels low and your diabetes in check.
Additive Effect With Sulphonylureas. Glycaemic Control May Be Affected By Diuretics, Corticosteroids, Phenothiazines, Thyroid Products, Oestrogens, Oral Contraceptives, Phenytoin, Nicotinic Acid, Sympathomimetics, Calcium Channel Blockers, Chlorpromazine And Isoniazid. Metformin Effects May Be Increased By ACE Inhibitors, Disopyramide, MAOIs. Cimetidine May Increase The Serum Levels Of Metformin. Concurrent Use With Contrast Agents May Increase The Risk Of Metformin-Induced Lactic Acidosis. May Decrease The Anticoagulant Effect Of Phenprocoumon, Therefore Routine Anticoagulant Monitoring Is Recommended. Potentially Fatal: Lactic Acidosis With Alcohol. Thrombocytopenia Has Been Reported With Ketotifen.
Warnings & Precautions
Below are the warnings and precautions to be taken when using Generic Glucophage (Metformin HCl Tablets): The risk of lactic acidosis caused by Metformin increases with the degree of renal dysfunction, impairment of creatinine clearance and the patient’s age. Patients which have serum keratinize levels above the upper limit of the normal range should not receive Metformin HCl.
Because impaired liver function can significantly limit the ability to clear lactate, Metformin should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.
Patients should be warned against excessive alcohol intake either acute or chronic when undergoing treatment with Metformin, since alcohol intake potentiates the effect of Metformin on lactate metabolism.
Treatment with Metformin should be temporarily discontinued 2 days prior to any intravascular radiocontrast study and not restarted until renal function has normalised.
It is advisable to discontinue metformin if stress conditions exist especially if gastrointestinal disturbances are noted or acidosis suspected. Therapy should only be resumed after lactic acidosis and ketoacidosis have been excluded.
Impairment of vitamin B12 and folic acid absorption has been seen to occur in some patients. Measurements of serum vitamin B12 and folic acid are advisable on an annual basis for patients receiving long-term therapy.
Hypoglycaemia does not normally occur in patients receiving treatment with Metformin alone, but can possibly occur when caloric intake is deficient, when strenuous exercise is not compensated by caloric supplementation, or during simultaneous use with other glucose lowering agents e.g. suphonylureas or ethanol.
The response to diabetic medicines such as Metformin HCl should be monitored by periodic measurements of fasting blood glucose and glycosylated haemoglobin levels. During initial dose titration period, fasting glucose measurements can be used to determine therapeutic response but thereafter both glucose and glycosylated haemoglobin should be monitored.
Acute Or Chronic Metabolic Acidosis With Or Without Coma (Including Diabetic Ketoacidosis). Renal Failure, Severe Renal Or Hepatic Impairment, Acute Conditions Which May Affect Renal Function E.G. Dehydration, Severe Infection Or Shock. Cardiac Failure, CHF, IDDM, Severe Impairment Of Thyroid Function; Acute Or Chronic Alcoholism. Acute Or Chronic Diseases Which May Cause Tissue Hypoxia E.G. Cardiac Or Respiratory Failure, Recent MI Or Shock. Pregnancy, Lactation.
Mostly you will be prescribed one 500mg Glycomet (Generic Glucomin) tablet 3 times a day, while the 850mg tablets are usually taken twice daily to give effective diabetes control. You should use Glycomet (Generic Glucomin) only as directed by your doctor.
- Nausea and vomiting
- Abdominal Pain
- Lactic Acidosis
- Chest discomfort
- Running nose
- Belching and Heartburn
- Swollen joints
- Metformin is the medicine of choice to lower blood sugar levels.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Glycomet.
- Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines.
- An upset stomach with nausea and diarrhoea may occur in the first two weeks; take it with food to avoid an upset stomach.
- Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol or on delaying/skipping a meal. Carry a sugar source with you for immediate relief.
- Notify your doctor if you have a kidney disease. Your doctor may adjust your dose.
- Vitamin B12 deficiency and symptoms of anemia like fatigue, pale skin, shortness of breath or headache may occur. Notify your doctor if you experience any of these as you may require supplements.
Frquantaly Asked Quation
How long the duration of effect?
- The effect lasts for an average duration of 4 to 8 hours.
what is the onset of action?
- The peak effect of this medicine can be observed after 1-3 hours of administration.
Are there any pregnancy warnings?
- This medicine is not recommended for use in pregnant women owing to the risk of abnormalities in the fetus. Alternate means of blood sugar control like insulin therapy should be considered during pregnancy.
Is it habit forming?
- No habit forming tendencies were reported.
Are there any breast-feeding warnings?
- This medicine is not recommended for use in breastfeeding women owing to the risk of adverse effects on the baby. Alternate means of blood sugar control like insulin therapy should be considered in such cases. If it becomes absolutely necessary to take this medicine, then breastfeeding should be discontinued.
Glycomet SR Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
- Type 2 diabetes mellitus
- Maturity onset diabetes
- Polycystic ovary syndrome
- Type 2 diabetes
Store Glycomet below 86 degrees F (30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Glycomet out of the reach of children and away from pets.